These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8269141)

  • 21. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term oral coagulation. Self monitoring prevents complication].
    MMW Fortschr Med; 2003 May; 145(19):53. PubMed ID: 12813982
    [No Abstract]   [Full Text] [Related]  

  • 24. High complication and failure rates of anticoagulant therapy are avoidable.
    Broekmans AW; Loeliger EA
    Z Kardiol; 1986; 75 Suppl 2():298-301. PubMed ID: 3727706
    [No Abstract]   [Full Text] [Related]  

  • 25. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
    Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Optimizing long-term anticoagulation by patient self-management?].
    Bernardo A
    Z Kardiol; 1998; 87 Suppl 4():75-81. PubMed ID: 9857471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose oral anticoagulation therapy in mechanical heart valve prostheses: the Italian experience.
    Di Nucci GD
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S86-7. PubMed ID: 15225013
    [No Abstract]   [Full Text] [Related]  

  • 28. Perioperative bleeding and thromboembolic risk during non-cardiac surgery in patients with mechanical prosthetic heart valves: an institutional review.
    Carrel TP; Klingenmann W; Mohacsi PJ; Berdat P; Althaus U
    J Heart Valve Dis; 1999 Jul; 8(4):392-8. PubMed ID: 10461238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The frequency of risk factors of thromboembolic and hemorrhagic complications in patients treated with oral anticoagulants after heart valve replacement].
    Wołkanin-Bartnik J; Zieliński T; Pogorzelska H; Browarek A; Leszek P; Korewicki J
    Pol Merkur Lekarski; 2005 May; 18(107):503-10. PubMed ID: 16161943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of hemorrhagic and thromboembolic complications in heart valve prosthesis].
    Pospelova EP; Stepanian EP; Shchurkalina TKh; Movsesian RA
    Grudn Khir; 1971; 13(1):49-51. PubMed ID: 5577527
    [No Abstract]   [Full Text] [Related]  

  • 32. Mitral valve replacement and thromboembolic risk.
    Benussi S; Verzini A; Alfieri O
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S81-3. PubMed ID: 15225011
    [No Abstract]   [Full Text] [Related]  

  • 33. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seventeen-year experience with the St. Jude medical biocor porcine bioprosthesis.
    Mykén PS
    J Heart Valve Dis; 2005 Jul; 14(4):486-92. PubMed ID: 16116875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of molecular markers for administration of anticoagulant therapy after heart valve replacement].
    Dahm M; Lotz J; Hafner G; Oelert H; Prellwitz W
    Z Kardiol; 1998; 87 Suppl 4():42-5. PubMed ID: 9857466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term follow up of 292 patients after valve replacement with the Omnicarbon prosthetic valve.
    Thevenet A; Albat B
    J Heart Valve Dis; 1995 Nov; 4(6):634-9. PubMed ID: 8611979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anticoagulant related hemorrhage and thromboembolism after valvular surgery].
    Okada K; Eishi K; Nakano K; Kobayashi J; Sasako Y; Isobe F; Kosakai Y; Kitoh Y
    Kyobu Geka; 1996 Mar; 49(3):190-3. PubMed ID: 8709422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clotting properties in diverse valve prostheses.
    Zöller H; Gross W; Rieke K
    Z Kardiol; 1986; 75 Suppl 2():338-40. PubMed ID: 3727715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of anticoagulants in preventing embolization from prosthetic heart valves.
    Gadboys HL; Litwak RS; Niemetz J; Wisch N
    JAMA; 1967 Oct; 202(4):282-6. PubMed ID: 6072302
    [No Abstract]   [Full Text] [Related]  

  • 40. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.